Foundation for innovation
in Cardiometabolism and Nutrition

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis

Hepatology

Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis

Restez en contact

Recevez toute l’actualité de la fondation ICAN

This field is for validation purposes and should be left unchanged.

Nos fondateurs

Nos soutiens institutionnels

Notre réseau